The latest revisions to international pharmacopoeia standards for glass pharmaceutical packaging has seen further harmonisation for testing requirements, and an increase in the necessity of delamination propensity studies across the pharmaceutical supply chain. In this article, Dan Capon, Laboratory Manager at Glass Technology Services explains how the latest revision to pharmacopoeia test methods will help simplify requirements between the US and European standards and possibly bring cost savings for customers that regularly test to both standards.
Origin
Glass Technology Services
Journal Title
www.Glass-Ts.com
Sector
News Items
Class
N 3471